1/12
08:30 am
mgx
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
Low
Report
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
12/3
04:32 pm
mgx
Metagenomi (NASDAQ:MGX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Metagenomi (NASDAQ:MGX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/1
07:13 am
mgx
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference [Yahoo! Finance]
High
Report
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference [Yahoo! Finance]
12/1
07:00 am
mgx
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
High
Report
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
11/27
02:50 pm
mgx
Metagenomi (NASDAQ:MGX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Metagenomi (NASDAQ:MGX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
08:00 am
mgx
Metagenomi to Present at Jefferies Global Healthcare Conference in London
Medium
Report
Metagenomi to Present at Jefferies Global Healthcare Conference in London